Status report
Get it in writing
The official USPTO status record for XCELLEREYES, serial 97016946, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELLEREYESSerial 97016946 · Principal Register
Live · Registered
Owner: Oculus Biologics, LLC.
Class 005 - Pharmaceuticals
Filed Sep 08, 2021
Registered Apr 18, 2023
The record shows that “XCELLEREYES” is a live, registered mark on the Principal Register, owned by Oculus Biologics, LLC. It protects biological tissue products for ocular wound care and degenerative eye conditions, specifically tissue grafts and related implants. A similar name would raise the closest concern if used for the same or closely related eye‑tissue products, but the record does not give the owner control over every use of the wording in other industries. The prosecution history shows a straightforward allowance and registration sequence with no descriptiveness refusal or Supplemental Register shift. The most recent event is the registration confirmation on April 18, 2023, and no further maintenance dates are supplied. No oppositions, cancellations, or enforcement actions appear in the supplied history. For someone considering a similar name, the risk is that using it for eye‑tissue products could conflict with this active, principal‑register mark.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.